ArticleBlood advances2025

Real-world outcomes of infections following tisagenlecleucel in patients with B-cell ALL: a CIBMTR analysis.

Hemalatha G Rangarajan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.